Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Spegra tablet is a fixed-dose combination antiretroviral medication manufactured by Emcure Pharmaceuticals Ltd, designed to treat HIV-1 infection in adults and adolescents (weighing at least 35-40kg). It combines three active ingredients—Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg)—into a single, once-daily tablet, enhancing adherence and reducing pill burden.
| Main Ingredients | Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg) |
| Storage | Store below 30°C, protect from moisture |
| Form | Film-coated tablet |
| Pack Sizes | 30 Tablets (bottle), 90 Tablets |
| Administration | Oral (daily) |
| Prescription | Prescription-only medication (Rx) |